Exchange: NYSE·Updated 04:10 PM EDT
News
all
press releases
Auna (AUNA) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
Transcript: Auna Q2 2026 Earnings Conference Call
Auna (NYSE:AUNA) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data andread more...
Benzinga
Auna S.A. (AUNA) Q2 Earnings Miss Estimates
Auna S.A. (AUNA) delivered earnings and revenue surprises of -42.31% and +2.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Auna Announces 2Q26 Financial Results
Auna (NYSE: AUNA) (Auna or the Company), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the second quarter ended June 30, 2026 (Second quarter 2026 or 2Q26). Financial results are expressed in Peruvian Soles (S/ or...
Business Wire
Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates
Cerenome (CNSY) delivered earnings and revenue surprises of -36.46% and -60.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates
Fate Therapeutics (FATE) delivered earnings and revenue surprises of +10.71% and +108.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Auna S.A. (AUNA) Expected to Beat Earnings Estimates: Should You Buy?
Auna S.A. (AUNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of +400.00% and +1.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
Progyny (PGNY) delivered earnings and revenue surprises of +7.84% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Solventum (SOLV) Q2 Earnings and Revenues Top Estimates
Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.